Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Dimension Therapeutics, Inc. | dmtx-10k_20151231.htm |
| XML - IDEA: XBRL DOCUMENT - Dimension Therapeutics, Inc. | R9999.htm |
| EX-32.1 - EX-32.1 - Dimension Therapeutics, Inc. | dmtx-ex321_665.htm |
| EX-31.1 - EX-31.1 - Dimension Therapeutics, Inc. | dmtx-ex311_666.htm |
| EX-21.1 - EX-21.1 - Dimension Therapeutics, Inc. | dmtx-ex211_667.htm |
| EX-31.2 - EX-31.2 - Dimension Therapeutics, Inc. | dmtx-ex312_664.htm |
| EX-10.15 - EX-10.15 - Dimension Therapeutics, Inc. | dmtx-ex1015_668.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-207-835) of Dimension Therapeutics, Inc. of our report dated March 24, 2016 relating to the consolidated financial statements, which appears in this Form 10 K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
March 24, 2016